TYMS and malignant colon neoplasm: Vorinostat (also known as SAHA, Figure 2) and LBH589 were reported to be able to downregulate thymidylate synthase (TS) gene expression in colon cancer cell lines, overcoming TS-mediated 5-FU resistance via enhancing cell cycle arrest and inhibiting cell growth [207].